Sign in
Not yet recruitingNo phase

Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)

Key facts

Who runs it
Ningbo Medical Center Lihuili Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
204 people, planned
Started
1 May 2026
Expected to end
31 Mar 2028
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Transcutaneous Electrical Acustimulation
Record updated
15 May 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age 18-75 years, irrespective of gender
  • Typical heartburn symptoms for at least 3 months
  • Heartburn on at least 2 days during the run-in diary period
  • Endoscopically confirmed NERD (no esophageal erosions, Los Angeles grade N or M) within 12 months
  • Willingness and ability to comply with all study procedures and to provide written informed consent

Who cannot take part

  • Familiarity with acupuncture points and their functions (e.g., previous acupuncture experience or medical training)
  • Any esophageal structural or mucosal disease (e.g., Barrett's esophagus, erosive esophagitis LA grade A-D, eosinophilic esophagitis, esophageal stricture, varices, malignancy, or prior chemical/thermal/radiation injury)
  • Inability to discontinue prohibited medications (PPIs, P-CABs, H2RAs, prokinetics, or other GERD-directed therapies) except for protocol-defined rescue medication during the study
  • Implanted electronic devices (e.g., pacemaker, defibrillator) or other implants susceptible to electrical stimulation
  • History of or suspected diagnosis of functional heartburn or functional dyspepsia by Rome IV criteria
  • Local skin disease or severe hypersensitivity at stimulation sites
  • Systemic diseases affecting gastrointestinal motility (e.g., systemic sclerosis, dermatomyositis, systemic lupus erythematosus, amyloidosis), uncontrolled diabetes mellitus (fasting glucose ≥11.1 mmol/L or glycated hemoglobin ≥7.0%), severe cardiovascular disease, significant hepatic or renal dysfunction, or severe psychiatric disorders
  • Presence of gastric or duodenal ulcers
  • Pregnancy, breastfeeding, or planned pregnancy during the study period
  • Participation in other interventional clinical trials within the past 3 months

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This multicenter study aims to evaluate whether Transcutaneous Electrical Acustimulation (TEA) is effective in treating Non-Erosive Gastroesophageal Reflux Disease (NERD). NERD is a common condition where patients experience symptoms like heartburn and regurgitation, but no visible damage can be seen in the esophagus during an endoscopy. TEA is a non-invasive treatment that uses a small device to deliver mild electrical stimulation through the skin on specific acupoints. This study will compare the effects of real TEA treatment with a sham (inactive) control. Participants will be randomly assigned to one of two groups: active TEA treatment or sham stimulation. Neither the participants nor the researchers evaluating the outcomes will know which treatment is being given. The main outcome is the improvement of reflux symptoms after 4 weeks of treatment. The results of this study may provide a new non-drug option for patients suffering from NERD.

The 2 groups in the trial

  • ST36 TEA GroupTreatment being tested

    Participants receive active transcutaneous electrical acustimulation (TEA) at the ST36 (Zusanli) acupoint unilaterally.

    Treatment: Transcutaneous Electrical Acustimulation

  • Sham TEA GroupSham treatment, for comparison

    Participants receive sham transcutaneous electrical acustimulation (TEA) with electrodes placed unilaterally at the olecranon and 3-5 cm vertically down from the olecranon.

    Treatment: Transcutaneous Electrical Acustimulation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD): A Multicenter, Randomized, Sham-Controlled Trial
Criteria questions
Built from NCT07572708, who can take part
Record updated
15 May 2026